Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
2019 Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC)
The goal of the Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) program is to reduce illness and related deaths caused by a wide range of infectious disease threats.
The ELC Program provides annual funding, strategic direction and technical
assistance to domestic jurisdictions for core capacities in epidemiology, laboratory, and health information technology activities.
In addition to strengthening core infectious disease capacities nationwide, this cooperative agreement also supports a myriad of specific infectious disease programs.The Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Notice of Funding Opportunity (NOFO) builds upon the program that was initiated in 1995 as one of the key activities under CDC’s plan to address emerging infectious disease threats.
The purpose of this NOFO is to protect the public health and safety of the American people by enhancing the capacity of public health agencies to effectively detect, respond, prevent and control known and emerging (or re-emerging) infectious diseases.
This is accomplished by providing financial and technical resources to (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.In the last five years, NCEZID’s extramural funding has increased from $109 million in FY 2013 to $302 million in FY 201 7. This increase coincides with increased responsibilities at the state and local level for emerging infectious disease control, notably for emergency responses to Ebola and Zika, and for expanded investment to curb antibiotic resistant infections and modernize public health laboratory capacity.
Ebola and Zika funding began as one-time emergency funding, while AR funding is expected to reoccur annually, and base vector-borne disease funding is beginning to grow.
Together with food- and water-borne disease program growth, these investments have moved from capacity building to program delivery.
In other infectious disease areas, capacity building is still the focus of investments.
The ELC Program provides annual funding, strategic direction and technical
assistance to domestic jurisdictions for core capacities in epidemiology, laboratory, and health information technology activities.
In addition to strengthening core infectious disease capacities nationwide, this cooperative agreement also supports a myriad of specific infectious disease programs.The Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC) Notice of Funding Opportunity (NOFO) builds upon the program that was initiated in 1995 as one of the key activities under CDC’s plan to address emerging infectious disease threats.
The purpose of this NOFO is to protect the public health and safety of the American people by enhancing the capacity of public health agencies to effectively detect, respond, prevent and control known and emerging (or re-emerging) infectious diseases.
This is accomplished by providing financial and technical resources to (1) strengthen epidemiologic capacity; (2) enhance laboratory capacity; (3) improve information systems; and (4) enhance collaboration among epidemiology, laboratory, and information systems components of public health departments.In the last five years, NCEZID’s extramural funding has increased from $109 million in FY 2013 to $302 million in FY 201 7. This increase coincides with increased responsibilities at the state and local level for emerging infectious disease control, notably for emergency responses to Ebola and Zika, and for expanded investment to curb antibiotic resistant infections and modernize public health laboratory capacity.
Ebola and Zika funding began as one-time emergency funding, while AR funding is expected to reoccur annually, and base vector-borne disease funding is beginning to grow.
Together with food- and water-borne disease program growth, these investments have moved from capacity building to program delivery.
In other infectious disease areas, capacity building is still the focus of investments.
Related Programs
Epidemiology and Laboratory Capacity for Infectious Diseases (ELC)
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: Centers for Disease Control - NCEZID
Estimated Funding: $1,500,000,000
Office: Centers for Disease Control - NCEZID
Estimated Funding: $1,500,000,000
Who's Eligible
Obtain Full Opportunity Text:
Endangered Species Program
Additional Information of Eligibility:
Specific ELC projects may have additional eligibility requirements associated with them.
If so, these will be noted in the project-specific attachments.
Full Opportunity Web Address:
http://www.fws.gov/endangered/recovery/champions/index.html
Contact:
Agency Email Description:
Grants Policy
Agency Email:
Date Posted:
2019-02-28
Application Due Date:
Archive Date:
2019-06-16
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
